SUCRAID

This brand name is authorized in United States

Active ingredients

The drug SUCRAID contains one active pharmaceutical ingredient (API):

1 Sacrosidase UNII 8A7F670F2Y - SACROSIDASE
Sacrosidase is a liquid enzyme preparation derived from baker’s yeast (Saccharomyces cerevisiae) used for the treatment of genetically determined sucrase deficiency, which is part of congenital sucrase-isomaltase deficiency (CSID). Read about Sacrosidase

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SUCRAID Oral solution	FDA, National Drug Code (US)	MPI, US: SPL/Old

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: US	FDA, National Drug Code	Identifier(s): 67871-111

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.